BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 9230886)

  • 1. Association of tumor angiogenesis with bone marrow micrometastases in breast cancer patients.
    Fox SB; Leek RD; Bliss J; Mansi JL; Gusterson B; Gatter KC; Harris AL
    J Natl Cancer Inst; 1997 Jul; 89(14):1044-9. PubMed ID: 9230886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer.
    Benoy IH; Salgado R; Elst H; Van Dam P; Weyler J; Van Marck E; Scharpé S; Vermeulen PB; Dirix LY
    Breast Cancer Res; 2005; 7(2):R210-9. PubMed ID: 15743502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow micrometastases and markers of angiogenesis in esophageal cancer.
    Spence GM; Graham AN; Mulholland K; Maxwell P; McCluggage WG; Sloan JM; McGuigan JA
    Ann Thorac Surg; 2004 Dec; 78(6):1944-9; discussion 1950. PubMed ID: 15561005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.
    Diel IJ; Kaufmann M; Costa SD; Holle R; von Minckwitz G; Solomayer EF; Kaul S; Bastert G
    J Natl Cancer Inst; 1996 Nov; 88(22):1652-8. PubMed ID: 8931609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of bone marrow micrometastases with sentinel lymph node status in early-stage breast cancer.
    Saha S; Ali S; Ghanem M; Soni M; Wiese D; Arora M; Singh T; Iddings D
    Ann Surg Oncol; 2009 Feb; 16(2):276-80. PubMed ID: 19050967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do bone marrow micrometastases correlate with sentinel lymph node metastases in breast cancer patients?
    Trocciola SM; Hoda S; Osborne MP; Christos PJ; Levin H; Martins D; Carson J; Daly J; Simmons RM
    J Am Coll Surg; 2005 May; 200(5):720-5; discussion 725-6. PubMed ID: 15848362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma.
    Axelsson K; Ljung BM; Moore DH; Thor AD; Chew KL; Edgerton SM; Smith HS; Mayall BH
    J Natl Cancer Inst; 1995 Jul; 87(13):997-1008. PubMed ID: 7543156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast carcinoma vascularity: a comparison of manual microvessel count and Chalkley count.
    Dhakal HP; Bassarova A; Naume B; Synnestvedt M; Borgen E; Kaaresen R; Schlichting E; Wiedswang G; Giercksky KE; Nesland JM
    Histol Histopathol; 2009 Aug; 24(8):1049-59. PubMed ID: 19554512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers.
    Wernicke AG; Varma S; Greenwood EA; Christos PJ; Chao KS; Liu H; Bander NH; Shin SJ
    APMIS; 2014 Jun; 122(6):482-9. PubMed ID: 24304465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis.
    Han Z; Chen Z; Zheng R; Cheng Z; Gong X; Wang D
    World J Surg Oncol; 2015 Feb; 13():56. PubMed ID: 25889325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Angiogenesis in Breast Cancer: Pericytes and Maturation Does Not Correlate With Lymph Node Metastasis and Molecular Subtypes.
    Shrivastav S; Bal A; Singh G; Joshi K
    Clin Breast Cancer; 2016 Apr; 16(2):131-8. PubMed ID: 26452314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer.
    Heimann R; Ferguson D; Powers C; Recant WM; Weichselbaum RR; Hellman S
    J Natl Cancer Inst; 1996 Dec; 88(23):1764-9. PubMed ID: 8944007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Completion axillary dissection can safely be omitted in screen detected breast cancer patients with micrometastases. A decade's experience from a single institution.
    Grabau D; Dihge L; Fernö M; Ingvar C; Rydén L
    Eur J Surg Oncol; 2013 Jun; 39(6):601-7. PubMed ID: 23579175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy.
    Braun S; Cevatli BS; Assemi C; Janni W; Kentenich CR; Schindlbeck C; Rjosk D; Hepp F
    J Clin Oncol; 2001 Mar; 19(5):1468-75. PubMed ID: 11230493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of angiogenesis by Chalkley counting in a confirmatory study design on 836 breast cancer patients.
    Hansen S; Grabau DA; Sørensen FB; Bak M; Vach W; Rose C
    Clin Cancer Res; 2000 Jan; 6(1):139-46. PubMed ID: 10656442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow micrometastases detected by RT-PCR for mammaglobin can be an alternative prognostic factor of breast cancer.
    Ooka M; Tamaki Y; Sakita I; Fujiwara Y; Yamamoto H; Miyake Y; Sekimoto M; Ohue M; Sugita Y; Miyoshi Y; Ikeda N; Noguchi S; Monden M
    Breast Cancer Res Treat; 2001 May; 67(2):169-75. PubMed ID: 11519865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microvessel density compared with the Chalkley count in a prognostic study of angiogenesis in breast cancer patients.
    Hansen S; Sørensen FB; Vach W; Grabau DA; Bak M; Rose C
    Histopathology; 2004 May; 44(5):428-36. PubMed ID: 15139990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer.
    Kaifi JT; Yekebas EF; Schurr P; Obonyo D; Wachowiak R; Busch P; Heinecke A; Pantel K; Izbicki JR
    J Natl Cancer Inst; 2005 Dec; 97(24):1840-7. PubMed ID: 16368946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast.
    Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S
    Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of laminin, laminin receptor, and bone marrow micrometastases in breast cancer patients: are these markers of aggressive behavior and metastatic potential?
    Molino A; Pedersini R; Micciolo R; Frisinghelli M; Giovannini M; Pavarana M; Santo A; Colato C; Piubello Q; Cetto GL
    Appl Immunohistochem Mol Morphol; 2003 Dec; 11(4):311-8. PubMed ID: 14663356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.